middle.news
How Control Bionics Is Driving 10% Revenue Growth and Expanding US Reach
8:30am on Friday 31st of October, 2025 AEDT
•
Medical Devices
Read Story
How Control Bionics Is Driving 10% Revenue Growth and Expanding US Reach
8:30am on Friday 31st of October, 2025 AEDT
Key Points
10% year-on-year revenue growth in Q1 FY26
US reimbursement coverage now exceeds 70% of population
NeuroStrip adoption grows in sports and rehabilitation sectors
Raised approximately $2.1 million through rights issue and shortfall placement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE